Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150750> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q64150750 description "clinical trial" @default.
- Q64150750 description "ensayu clínicu" @default.
- Q64150750 description "klinisch onderzoek" @default.
- Q64150750 description "клінічне випробування" @default.
- Q64150750 name "Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations" @default.
- Q64150750 type Item @default.
- Q64150750 label "Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations" @default.
- Q64150750 prefLabel "Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations" @default.
- Q64150750 P1050 Q64150750-135F6F5A-11CC-4C8C-9E90-6B0110250BA1 @default.
- Q64150750 P1050 Q64150750-5A2E674E-CBDE-4CF9-A0F2-3A62B0F5B56D @default.
- Q64150750 P1132 Q64150750-49BA3C9D-6055-4E57-99CC-265BDF10C024 @default.
- Q64150750 P1476 Q64150750-8FAF0C00-5247-45E4-9092-CCC6E21C0D8A @default.
- Q64150750 P17 Q64150750-7A1E5D58-941A-41AB-82B5-2E738D54FDF1 @default.
- Q64150750 P2899 Q64150750-0AB9B30B-C916-47CF-8403-04048F463BAB @default.
- Q64150750 P3098 Q64150750-D23C2458-4D36-4C7A-BC02-7D35E4BE17D3 @default.
- Q64150750 P31 Q64150750-2A9AACD7-2374-43C5-AEA9-1D116C57F786 @default.
- Q64150750 P580 Q64150750-609B42F4-2855-48A0-9B6E-D98AAF5DCA99 @default.
- Q64150750 P582 Q64150750-77C46F6F-426E-4519-AE45-1CBA41FA7763 @default.
- Q64150750 P6099 Q64150750-309E3459-E593-4041-91C2-5108D48B27D3 @default.
- Q64150750 P6153 Q64150750-1AAB4F3D-E277-4A3B-9A82-CA6B8635B5A5 @default.
- Q64150750 P6153 Q64150750-3E9C5C06-69CE-4B68-959B-67C9D976B30D @default.
- Q64150750 P6153 Q64150750-4355048F-775E-4AD6-8F56-9D304F3F44D6 @default.
- Q64150750 P6153 Q64150750-536513F6-A13D-457C-9897-A5B644E6B19F @default.
- Q64150750 P6153 Q64150750-61000A5D-32DD-40F7-8B19-D42FC016B9E6 @default.
- Q64150750 P6153 Q64150750-64C8528F-C138-41D0-9553-CBB4B55E826A @default.
- Q64150750 P6153 Q64150750-70EADB4A-EDB9-4412-B872-F850095FDD0C @default.
- Q64150750 P6153 Q64150750-99D4264C-D3C6-47A6-8455-D97E1EAB6B83 @default.
- Q64150750 P6153 Q64150750-ABD09371-DF1E-49E4-A12B-7F72BC7BCE47 @default.
- Q64150750 P6153 Q64150750-DD9A7FBE-052E-4586-9701-E0893AB4122B @default.
- Q64150750 P6153 Q64150750-EBA02ED1-2D73-41AD-BEB0-DACF4B443807 @default.
- Q64150750 P6153 Q64150750-EEAC0D34-C396-4BE0-B3F9-FB6A13675DE6 @default.
- Q64150750 P6153 Q64150750-F000C944-A02A-4B5F-A431-3021DE6EAEC7 @default.
- Q64150750 P8363 Q64150750-98D37F9B-13D9-41D5-8A2B-4677AB58EA4B @default.
- Q64150750 P1050 Q124292 @default.
- Q64150750 P1050 Q1365309 @default.
- Q64150750 P1132 "+145" @default.
- Q64150750 P1476 "A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 Mutant Advanced Solid Tumors" @default.
- Q64150750 P17 Q30 @default.
- Q64150750 P2899 "+18" @default.
- Q64150750 P3098 "NCT03212274" @default.
- Q64150750 P31 Q30612 @default.
- Q64150750 P580 "2018-03-30T00:00:00Z" @default.
- Q64150750 P582 "2019-07-31T00:00:00Z" @default.
- Q64150750 P6099 Q42824440 @default.
- Q64150750 P6153 Q1159198 @default.
- Q64150750 P6153 Q192334 @default.
- Q64150750 P6153 Q193727 @default.
- Q64150750 P6153 Q235034 @default.
- Q64150750 P6153 Q2900977 @default.
- Q64150750 P6153 Q29052 @default.
- Q64150750 P6153 Q30279912 @default.
- Q64150750 P6153 Q309331 @default.
- Q64150750 P6153 Q333886 @default.
- Q64150750 P6153 Q4897536 @default.
- Q64150750 P6153 Q49112 @default.
- Q64150750 P6153 Q499451 @default.
- Q64150750 P6153 Q7972509 @default.
- Q64150750 P8363 Q78089383 @default.